Amy H. Newman
Affiliations: | Medicinal Chemistry | National Institutes of Health, Bethesda, MD |
Area:
G-protein coupled receptorsWebsite:
http://irp.drugabuse.gov/Newman.phpGoogle:
"Amy H. Newman"Bio:
http://www.chemheritage.org/discover/collections/oral-histories/details/newman-amy-h.aspx
http://www.chemheritage.org/discover/online-resources/women-in-chemistry/beyond-the-legend-of-marie-curie.aspx?page=3
http://www.chemheritage.org/Oral-Histories/Documents/A-Newman--Front-Matter-and-Index.pdf
Mean distance: 21.77 | S | N | B | C | P |
Cross-listing: Neurotree
Parents
Sign in to add mentor| Richard A. Glennon | grad student | 1985 | VCU |
| Kenner C. Rice | post-doc | 1985-1988 | NIDDK, NIH |
Children
Sign in to add trainee| Michael P. Ellenberger | research assistant | NIH (NIDA) | |
| Thomas M. Keck | post-doc | 2009-2014 | NIDA Intramural Research Program (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Panayi MC, Shetty S, Porod M, et al. (2024) The selective DReceptor antagonist VK4-116 reverses loss of insight caused by self-administration of cocaine in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Bonifazi A, Ellenberger M, Farino ZJ, et al. (2024) Development of novel tools for dissection of central versus peripheral dopamine D -like receptor signaling in dysglycemia. Biorxiv : the Preprint Server For Biology |
| Hersey M, Mereu M, Jones CS, et al. (2024) Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats. The European Journal of Neuroscience |
| Ecevitoglu A, Meka N, Rotolo RA, et al. (2024) Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Ku TC, Cao J, Won SJ, et al. (2024) Series of (([1,1'-Biphenyl]-2-yl)methyl)sulfinylalkyl Alicyclic Amines as Novel and High Affinity Atypical Dopamine Transporter Inhibitors with Reduced hERG Activity. Acs Pharmacology & Translational Science. 7: 515-532 |
| García-Nafría J, Arroyo-Urea S, Nazarova A, et al. (2023) Structure of the dopamine D3 receptor bound to a bitopic agonist reveals a new specificity site in an expanded allosteric pocket. Research Square |
| Okorom AV, Camacho-Hernandez GA, Salomon K, et al. (2023) Modifications to 1-(4-(2-Bis(4-fluorophenyl)methyl)sulfinyl)alkyl Alicyclic Amines That Improve Metabolic Stability and Retain an Atypical DAT Inhibitor Profile. Journal of Medicinal Chemistry |
| Panayi MC, Shetty S, Porod M, et al. (2023) The selective D3-Receptor antagonist VK4-116 effectively treats behavioral inflexibility in rats caused by self-administration and withdrawal from cocaine. Biorxiv : the Preprint Server For Biology |
| Boateng CA, Nilson AN, Placide R, et al. (2023) Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder. Journal of Medicinal Chemistry |
| Bonifazi A, Saab E, Sanchez J, et al. (2023) Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D (DR) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics. Journal of Medicinal Chemistry |